-
29 April 2025 23:07:09
- Source: Sharecast
29 April 2025
LEI 213800RG7JNX7K8F7525
Life Science REIT plc
("Life Science REIT" or the "Company")
Annual Report and Notice of Annual General Meeting ("AGM")
Following the announcement on 16 April 2025 of its full year results for the year ended 31 December 2024 (RNS number: 1859F), the Company has today posted the following documents to shareholders that have elected to receive hard copies of shareholder communications:
· 2024 Annual Report;
· Notice of 2025 Annual General Meeting (AGM); and
· Letter of Availability.
In accordance with UK Listing Rules 6.4.1R and 6.4.3R and UK Disclosure Guidance and Transparency Rules ("DTRs") 6.2.10R and 6.3.5R, the 2024 Annual Report has been submitted to the Financial Conduct Authority's National Storage Mechanism in both structured electronic format and in unedited full text and the Notice of the 2025 AGM has been submitted to the NSM. A copy of the 2024 Annual Report and the Notice of the 2025 AGM will shortly be available for viewing at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The AGM will be held at the offices of Ironstone Asset Management Limited, 3rd Floor, 55 Wells Street, London, W1T 3PT at 10.00am on Tuesday 3 June 2025.
Enquiries:
|
Ironstone Asset Management - Investment Adviser |
+44 20 3011 2160 |
|
Simon Farnsworth, Managing Director Simon.farnsworth@ironstoneam.com
|
|
|
Joanna Waddingham, Head of Investor Relations and Corporate Affairs Joanna.Waddingham@ironstoneam.com
|
|
|
MUFG Corporate Governance Limited - Company Secretary labs_cosec@cm.mpms.mufg.com
|
|
|
Panmure Liberum - Financial Adviser & Corporate Broker Alex Collins / Tom Scrivens
|
+44 20 7886 2500 |
|
G10 Capital Limited - AIFM Maria Baldwin
|
+44 20 7397 5450 |
|
FTI Consulting - Financial PR Dido Laurimore / Richard Gotla / Oliver Parsons LifeScienceReit@fticonsulting.com |
+44 20 3727 1000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.